$2.47
-0.05 (-1.98%)
Open$2.49
Previous Close$2.52
Day High$2.49
Day Low$2.41
52W High$74.94
52W Low$1.92
Volume—
Avg Volume13.6K
Market Cap2.69M
P/E Ratio10.40
EPS$1,612.06
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 462.8K | 474.7K | 442.2K |
| Net Income | -17,156 | -18,549 | -17,491 |
| Profit Margin | -3.7% | -3.9% | -4.0% |
| EBITDA | -38,868 | -39,496 | -31,996 |
| Free Cash Flow | -11,585 | -14,526 | -17,935 |
| Rev Growth | +1.4% | -0.9% | -6.2% |
| Debt/Equity | 0.29 | 0.36 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |